Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

ClinicalTrials.gov ID: NCT01284517

Public ClinicalTrials.gov record NCT01284517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 6-week Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression in Subjects Demonstrating Non-response to Treatment With Lithium or Divalproex Alone.

Study identification

NCT ID
NCT01284517
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
356 participants

Conditions and interventions

Interventions

  • Lurasidone Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Jul 31, 2012
Completion
Jul 31, 2012
Last update posted
Nov 25, 2013

2010 – 2012

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Clinical Innovations, Inc. Costa Mesa California 92647
Clinical Innovations Inc. Riverside California 92506
Artemis Institute for Clinical Research San Diego California 92123
Sharp Mesa Vista Hospital San Diego California 92123
Clinical Innovations inc. Santa Ana California 92705
Collaborative Neuroscience Network Torrance California 90502
Colorado Clinical Trials Inc. Highlands Ranch Colorado 80130
Accurate Clinical Trials Kissimmee Florida 34741
Clinical Neuroscience Solutions Inc. Orlando Florida 32806
Northwest Behavioral Research Center Roswell Georgia 30076
Institute for Behavioral Medicine LLC Smyrna Georgia 30080
Precise Research Centers Flowood Mississippi 39232
Village Clinical Research Inc. New York New York 10003
Medical & Behavioral Health Research New York New York 10023
Zarzar Psychiatric Associates, PLLC Raleigh North Carolina 27607
Summit Research Network (Oregon) Inc. Portland Oregon 97210
Lehigh Valley Hospital Allentown Pennsylvania 18103
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
FutureSearch Clinical Trials, LP Dallas Texas 75231
Pillar Clinical Research Dallas Texas 75243
Red Oak Psychiatry Associates, PA Houston Texas 77090
Summit Research Network (Seattle) LLC Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01284517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2013 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01284517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →